DATASET RE-READ 2026-11-2042 PROGRAMSNEXLIFE PRICES READ 2026-11-20EVERY FIGURE CARRIES ITS READ DATE
TopGLP1Providers.comverified price index
DATED PRICES

ShedRx vs Yucca Health: November 2026 prices compared

As of November 20, 2026, from each program’s own page: on compounded tirzepatide, only Yucca Health prints a comparable month-to-month price, $139 a month; ShedRx shows only a starting-dose or coupon figure (from $239, "starting as low as"), so no like-for-like comparison is possible.

Released · Last reviewed · how we verify

On compounded semaglutide, only Yucca Health prints a comparable month-to-month price, $89 a month; ShedRx shows only a starting-dose or coupon figure (from $159, "GLP-1s from $159/mo" (drug not named)), so no like-for-like comparison is possible.

ShedRx and Yucca Health, measure by measure

ShedRx and Yucca Health side by side, from each program’s own page read November 20, 2026 (all-in: medication plus any required recurring fee, before tax)
MeasureShedRxYucca Health
Tirzepatide, month to monthfrom $239 (lowest printed: "starting as low as"; no month-to-month figure)$139 (per month)
Tirzepatide, lowest printed$239 ("starting as low as")$119 (12-month plan, $1,428 upfront)
Semaglutide, month to monthfrom $159 (lowest printed: "GLP-1s from $159/mo" (drug not named); no month-to-month figure)$89 (per month)
Semaglutide, lowest printed$159 ("GLP-1s from $159/mo" (drug not named))$69 (12-month plan, $828 upfront)
Dose pricingpriced by dose or not statedsame price at every dose
Membership or program feenonenone
Computed score12 of 40 (position 16 of 27)34.7 of 40 (position 2 of 27)
FDA warning lettersnone listednone listed
November 20 readfirst-party readfirst-party read, changed

Strengths and limitations: which fits whom

ShedRx prints a month-to-month price; confirm whether it changes with the dose before you rely on it for a year. Yucca Health prints one price at every dose with no membership, so a dose increase does not change the bill. Compounded tirzepatide and semaglutide are not FDA-approved and are not the same products as Zepbound or Wegovy; a licensed clinician decides whether either is appropriate for you.

What changed since August

The first version of this comparison used captures from August 5–10, 2026. The November 20 re-read replaces them; the August figures are kept below as history, dated.

What changed since the August 2026 capture (maintenance-dose all-in figure then; month-to-month all-in figure read November 20, 2026)
ProgramMedicationAugust 5–10, 2026November 20, 2026
ShedRxtirzepatide—from $239
ShedRxsemaglutide—from $159
Yucca Healthtirzepatide—$139
Yucca Healthsemaglutide—$89
Check ShedRx’s current prices ↗
Check Yucca Health’s current prices ↗

Frequently asked

Which is cheaper, ShedRx or Yucca Health?

On compounded tirzepatide, only Yucca Health prints a comparable month-to-month price, $139 a month; ShedRx shows only a starting-dose or coupon figure (from $239, "starting as low as"), so no like-for-like comparison is possible. On compounded semaglutide, only Yucca Health prints a comparable month-to-month price, $89 a month; ShedRx shows only a starting-dose or coupon figure (from $159, "GLP-1s from $159/mo" (drug not named)), so no like-for-like comparison is possible.

Do ShedRx and Yucca Health charge a membership fee?

ShedRx: no membership fee; Yucca Health: no membership fee. This site folds any required recurring fee into the all-in figures above, so the comparison already counts it.

Are ShedRx and Yucca Health medications FDA-approved?

Compounded tirzepatide and semaglutide from any telehealth program are not FDA-approved and are not the same products as Zepbound, Mounjaro, Wegovy or Ozempic. Brand medications sold through a manufacturer or a brand route are FDA-approved. Ask each program which pharmacy fills the prescription.

ShedRx recordShedRx alternativesYucca Health recordYucca Health alternativesAll head-to-headsRankingsPrice database

Sources

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.